ICUI 82.38 Icu Medical $ICUI Hit a 52 week high of 82.60

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 12:26 PM

ICUI 82.38 Icu Medical $ICUI Hit a 52 week high of 82.60 Closing the day 09:45 at 82.38 +1.51 +1.87% With a day low of 80.09 and a total volume of 27,718.

ICUI Recent Posts: http://investorshangout.com/ICU-Medical-Inc-ICUI-54414/

ICUI Icu Medical Recent Headline News

INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 83.23 (+2.36), INSY: 38.91 (-2.61), ABAX: 53.42 (-0.08), GWPH: 74.72 (-0.05)

ICU Medical Up 30.0% Since SmarTrend Uptrend Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 5:12PM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 30.02% as of today's recent price of $80.87.
ICUI: 83.23 (+2.36)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 83.23 (+2.36), OREX: 5.99 (+0.95), PCMI: 8.91 (+0.01), CYAN: 5.92 (-0.14), ACHN: 13.13 (+0.65), TGTX: 13.26 (+0.35), AGIO: 87.08 (+5.17), LIOX: 5.44 (+0.01), SAJA: 6.25 (+0.65), PLNR: 6.93 (+0.12)

After Yesterday's Rally of 12.62% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 4:23PM CST
ICU Medical (NASDAQ:ICUI) traded in a range yesterday that spanned from a low of $80.15 to a high of $87.50. Yesterday, the shares gained 12.6%, which took the trading range above the 3-day high of $72.30 on volume of 950,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ICUI: 83.23 (+2.36)

Omnicell Reports Mixed Q3, Positive on Surgichem Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:00PM CST
On Nov 6, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), OMCL: 31.70 (+0.01)

Boston Scientific Shows Strength on Core Market Stabilization - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:50PM CST
On Nov 7, 2014, we issued an updated research report on leading medical devices company Boston Scientific Corporation (BSX).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), BCR: 164.11 (-0.16), ABAX: 53.42 (-0.08)

Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST

FSM: 4.30 (-0.12), HEAR: 4.06 (+0.09), JRJC: 7.38 (-0.11), CVO: 1.71 (+0.15), AAOI: 12.05 (+0.31), UNIS: 3.01 (+0.06), HIIQ: 8.65 (-0.58), CYAN: 5.92 (-0.14), PTX: 11.06 (-0.29), TRMR: 2.90 (+0.17), PRKR: 1.08 (-0.01), SUMR: 2.81 (+0.18), VSLR: 12.10 (+0.68), RVP: 3.97 (-0.16), ASCMA: 51.46 (+0.10), ICUI: 83.23 (+2.36), CALL: 8.52 (unch), DMD: 5.86 (-0.07), AST: 3.99 (+0.37), ASEI: 45.82 (-1.19)

Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), GWPH: 74.72 (-0.05), EGRX: 12.81 (-0.72)

Upgrade Alert for ICU Medical (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 6:59AM CST
ICU Medical (NASDAQ:ICUI) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $71.81 on volume of 194,000 shares, above average daily volume of 126,000. ICU Medical share prices have moved between a 52-week high of $85.00 and a 52-week low of $35.58 and closed yesterday at 102% above that low price at $71.81 per share. The 200-day and 50-day moving averages have moved 0.16% higher and 0.83% higher over the past week, respectively.
ICUI: 83.23 (+2.36)

ICU Medical posts 3Q profit
Automated Insights - Tue Nov 11, 4:11AM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Tuesday reported profit of $6.4 million in its third quarter.
ICUI: 83.23 (+2.36)

ICU Medical's (ICUI) CEO Vivek Jain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 6:51PM CST

ICUI: 83.23 (+2.36)

ICU Medical beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:32PM CST

ICUI: 83.23 (+2.36)

ICU Medical (ICUI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

ICUI: 83.23 (+2.36)

ICU Medical, Inc. Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"

, a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the third quarter and nine months ended September 30, 2014.
ICUI: 83.23 (+2.36)

Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), WAG: 67.29 (-0.21)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST

HK: 3.01 (-0.01), WWD: 50.96 (+2.26), LLNW: 2.72 (+0.03), FXEN: 2.76 (+0.04), RMTI: 10.95 (-0.20), CZR: 14.21 (+3.07), EGY: 7.14 (-0.05), ICUI: 83.23 (+2.36), ICEL: 7.54 (+0.01), SAAS: 8.88 (-0.18), DMD: 5.86 (-0.07), NPSP: 28.86 (-0.55), SCLN: 8.39 (+0.15), ATHX: 1.42 (-0.07), CMLS: 3.31 (-0.02), TC: 2.12 (-0.03), ATW: 35.57 (-0.68), CLUB: 6.09 (-0.05), RAX: 42.04 (-0.21), PTLA: 27.32 (+0.07), IPAR: 28.77 (-0.39), ATLS: 36.87 (-0.21), AMBC: 26.10 (+1.29), CUI: 7.95 (+0.06), PDLI: 8.03 (-0.08), OMER: 19.10 (+0.05), PRAA: 61.89 (+0.24), CARA: 8.16 (-0.32), HALO: 8.80 (-0.02), MODN: 10.47 (+0.01), CALL: 8.52 (unch), ASEI: 45.82 (-1.19), HGR: 20.10 (-0.43), ERII: 4.62 (+0.19)

BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), BIOS: 5.77 (+0.04)

Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), OMCL: 31.70 (+0.01)

ICU Medical Inc. (ICUI) Stock Research Links

ICUI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...